|
- The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
|
|
- The group's high margin levels account for strong profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Historically, the company has been releasing figures that are above expectations.
- Within the weekly time frame the stock shows a bullish technical configuration above the support level at 166 SEK
|
|
- Stock prices approach a strong long-term resistance in weekly data at SEK 250.2.
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- With an enterprise value anticipated at 5.57 times the sales for the current fiscal year, the company turns out to be overvalued.
- For the past seven days, analysts have been lowering their EPS expectations for the company.
|
|
|
Sector Semiconductor Equipment & Testing - NEC |
|
| | 1st jan. | Capitalisation (M$) | Investor Rating |
 |
 | MYCRONIC AB (PUBL) | -5.05% | 2 728 | |
|
| |
|
Sales 2020 |
3 921 M
474 M
474 M
|
Net income 2020 |
686 M
83,0 M
83,0 M
|
Net cash 2020 |
936 M
113 M
113 M
|
P/E ratio 2020 |
33,9x |
Yield 2020 |
1,19% |
|
Capitalization |
23 270 M
2 806 M
2 814 M
|
EV / Sales 2020 |
5,70x |
EV / Sales 2021 |
5,13x |
Nbr of Employees |
1 505 |
Free-Float |
72,2% |
|
Upcoming event on MYCRONIC AB (PUBL)
Notations Surperformance©
Fundamental ratings
|
Overall rating |
Trading Rating |
|
Investor Rating |
|
Growth (Revenue) |
|
Valuation |
|
Finances |
|
Profitability |
|
Earnings quality |
|
Business Predictability |
|
P/E ratio |
|
Potential |
|
Yield |
|
Consensus |
- |
7 days EPS revision |
|
4 months EPS revision |
|
1 year EPS revision |
|
4 months Revenue revision |
|
1 year Revenue revision |
|
Technical ratings
Short Term Timing |
|
Middle Term Timing |
|
Long Term Timing |
|
RSI |
|
Bollinger Spread |
|
Unusual Volumes |
|
|